Biological Products, (No Diagnostic Substances)
SIC 2836 144 tickers analyzed 5,947 total alerts
📈 Sector Performance by Timeframe
5-Minute
15-Minute
30-Minute
60-Minute
EOD
MFE/MAE
📋 Biological Products, (No Diagnostic Substances) Stocks (100)
All tickers in SIC 2836 with Trade-Ideas alert data, sorted by alert count.
| # | Ticker | Company | Market Cap | Alerts | Avg Win Rate | Avg 5min | MFE | Action |
|---|---|---|---|---|---|---|---|---|
| 1 | DNA | $831.7M | 446 | 43.0% | -0.60% | +4.05% | View → | |
| 2 | OCGN | $345.9M | 418 | 39.2% | -0.51% | +3.74% | View → | |
| 3 | NVAX | $1.73B | 358 | 44.6% | -0.21% | +5.10% | View → | |
| 4 | RXRX | $2.21B | 287 | 48.0% | -0.11% | +4.08% | View → | |
| 5 | MRNA | $75.86B | 241 | 51.7% | +0.10% | +4.21% | View → | |
| 6 | OTLK | $144.4M | 193 | 45.7% | -0.35% | +8.11% | View → | |
| 7 | IBRX | $10.90B | 188 | 48.1% | -0.37% | +7.02% | View → | |
| 8 | GILD | $179.47B | 161 | 55.4% | +0.05% | +1.25% | View → | |
| 9 | PALI | $250.9M | 152 | 43.5% | -0.16% | +8.56% | View → | |
| 10 | IOVA | $6.44B | 121 | 49.6% | +0.19% | +5.49% | View → | |
| 11 | TNYA | $126.5M | 116 | 39.1% | -0.49% | +4.62% | View → | |
| 12 | AIM | $7.2M | 110 | 47.5% | +0.39% | +9.36% | View → | |
| 13 | HUMA | $144.9M | 105 | 43.6% | -0.47% | +5.64% | View → | |
| 14 | AMGN | $217.90B | 101 | 51.1% | +0.02% | +1.25% | View → | |
| 15 | LIMN | $5.2M | 100 | 49.0% | -0.17% | +9.56% | View → | |
| 16 | CLDI | $2.8M | 98 | 38.4% | -0.31% | +6.18% | View → | |
| 17 | GRML | $60.0M | 80 | 32.0% | -0.42% | +8.24% | View → | |
| 18 | SGMO | - | 75 | 44.8% | +0.12% | +9.76% | View → | |
| 19 | CGTX | $88.0M | 74 | 39.8% | -0.74% | +7.07% | View → | |
| 20 | PHGE | $5.0M | 71 | 47.4% | +0.06% | +8.83% | View → | |
| 21 | QNCX | $29.7M | 70 | 35.8% | -1.54% | +10.00% | View → | |
| 22 | SNTI | $10.0M | 68 | 42.6% | -0.80% | +15.20% | View → | |
| 23 | PLX | $218.3M | 67 | 44.8% | -0.25% | +4.61% | View → | |
| 24 | SLXN | $1.4M | 65 | 49.4% | -0.19% | +11.86% | View → | |
| 25 | CELZ | $7.2M | 63 | 43.4% | +0.34% | +11.51% | View → | |
| 26 | XFOR | $280.6M | 58 | 37.6% | -1.96% | +8.49% | View → | |
| 27 | CHRS | $179.2M | 58 | 44.8% | -0.19% | +6.56% | View → | |
| 28 | IVVD | $242.3M | 53 | 37.7% | -1.02% | +11.51% | View → | |
| 29 | TVGN | $45.5M | 52 | 31.5% | -0.40% | +10.91% | View → | |
| 30 | BCAB | $2.9M | 51 | 42.5% | -0.57% | +8.60% | View → | |
| 31 | BCRX | $2.09B | 49 | 51.8% | -0.53% | +4.61% | View → | |
| 32 | CCCC | $362.9M | 49 | 54.3% | +0.42% | +10.68% | View → | |
| 33 | ATRA | $95.2M | 47 | 57.5% | +0.52% | +11.96% | View → | |
| 34 | BIIB | $32.49B | 45 | 44.4% | -0.32% | +1.31% | View → | |
| 35 | DBVT | $663.1M | 44 | 42.2% | -0.12% | +5.94% | View → | |
| 36 | AGEN | $377.6M | 43 | 49.3% | -0.79% | +6.44% | View → | |
| 37 | CRIS | $1.9M | 43 | 42.1% | -0.47% | +10.54% | View → | |
| 38 | CMPX | $154.3M | 39 | 50.3% | -0.01% | +7.05% | View → | |
| 39 | CABA | $339.1M | 37 | 45.4% | -0.57% | +9.24% | View → | |
| 40 | CRDF | $87.1M | 37 | 35.9% | +0.28% | +7.87% | View → | |
| 41 | SANA | $865.2M | 37 | 33.0% | +0.09% | +5.08% | View → | |
| 42 | REPL | $1.23B | 36 | 56.7% | -0.25% | +9.14% | View → | |
| 43 | AUTL | $473.8M | 35 | 38.9% | -0.52% | +4.93% | View → | |
| 44 | BCDA | $15.7M | 35 | 45.5% | -0.28% | +9.47% | View → | |
| 45 | TSHA | $1.51B | 34 | 39.4% | -0.55% | +9.44% | View → | |
| 46 | VIVS | $2.6M | 33 | 33.4% | +0.24% | +7.01% | View → | |
| 47 | ATYR | $28.2M | 32 | 41.9% | -0.40% | +5.90% | View → | |
| 48 | RLAY | $4.15B | 32 | 53.1% | +0.18% | +5.76% | View → | |
| 49 | SCLX | $28.6M | 31 | 43.2% | -0.46% | +6.87% | View → | |
| 50 | CVM | $40.6M | 30 | 40.7% | -0.10% | +13.01% | View → | |
| 51 | SLDB | $734.5M | 30 | 56.7% | -0.30% | +8.71% | View → | |
| 52 | CADL | $779.0M | 30 | 51.3% | +0.98% | +13.71% | View → | |
| 53 | CRSP | $5.36B | 29 | 47.6% | -0.10% | +4.39% | View → | |
| 54 | INAB | $13.8M | 29 | 42.0% | -0.66% | +10.13% | View → | |
| 55 | DTIL | $174.2M | 28 | 39.6% | -0.85% | +4.42% | View → | |
| 56 | FATE | $278.0M | 27 | 63.0% | +2.27% | +9.86% | View → | |
| 57 | EDIT | $402.4M | 27 | 44.4% | +0.75% | +7.15% | View → | |
| 58 | BDTX | $108.6M | 27 | 25.9% | -1.01% | +5.18% | View → | |
| 59 | SCNI | - | 26 | 38.3% | +1.36% | +9.96% | View → | |
| 60 | ADMA | $2.18B | 26 | 53.8% | +0.18% | +5.66% | View → | |
| 61 | ALLO | $518.2M | 26 | 36.2% | -0.35% | +5.40% | View → | |
| 62 | KOD | $5.94B | 25 | 54.4% | +0.52% | +10.90% | View → | |
| 63 | RGNX | $490.5M | 24 | 36.7% | -0.59% | +4.45% | View → | |
| 64 | PRME | $540.5M | 24 | 49.2% | +0.25% | +5.90% | View → | |
| 65 | IMVT | $6.94B | 24 | 55.8% | +0.64% | +6.88% | View → | |
| 66 | JSPR | $18.8M | 24 | 46.7% | +0.44% | +16.82% | View → | |
| 67 | IKT | $279.1M | 23 | 36.2% | -0.87% | +7.69% | View → | |
| 68 | CRBU | $130.8M | 20 | 41.0% | -0.47% | +5.17% | View → | |
| 69 | BEAM | $2.53B | 20 | 54.0% | -0.04% | +6.06% | View → | |
| 70 | NMRA | $93.9M | 20 | 51.5% | +0.34% | +11.53% | View → | |
| 71 | INTS | $11.2M | 19 | 30.1% | -0.23% | +5.87% | View → | |
| 72 | KLTO | $23.7M | 18 | 41.1% | -0.48% | +14.35% | View → | |
| 73 | AVXL | $168.7M | 18 | 30.0% | -0.94% | +5.30% | View → | |
| 74 | BNTX | $24.34B | 17 | 49.4% | +0.17% | +2.85% | View → | |
| 75 | ALGS | $34.6M | 17 | 43.2% | -2.19% | +7.79% | View → | |
| 76 | NBIX | $14.55B | 16 | 62.5% | +0.05% | +1.77% | View → | |
| 77 | TCRX | $21.7M | 16 | 48.1% | -0.11% | +17.56% | View → | |
| 78 | RVMD | $44.29B | 16 | 42.5% | -1.79% | +3.88% | View → | |
| 79 | HALO | $12.47B | 15 | 49.2% | -0.45% | +2.45% | View → | |
| 80 | SABS | $271.1M | 15 | 34.0% | -2.10% | +11.81% | View → | |
| 81 | ABOS | $147.5M | 15 | 32.0% | +0.32% | +9.47% | View → | |
| 82 | VIR | $1.89B | 15 | 30.7% | -1.26% | +4.23% | View → | |
| 83 | GLUE | $895.8M | 13 | 41.5% | -1.01% | +10.67% | View → | |
| 84 | KYTX | $384.7M | 13 | 35.4% | -0.54% | +3.39% | View → | |
| 85 | PCVX | $8.40B | 13 | 52.3% | +0.50% | +4.44% | View → | |
| 86 | INMB | $53.6M | 13 | 60.0% | -0.04% | +7.00% | View → | |
| 87 | ENTX | $495.2M | 13 | 40.8% | -1.91% | +21.68% | View → | |
| 88 | TECH | $11.35B | 12 | 48.5% | -0.46% | +1.46% | View → | |
| 89 | SRZN | $344.6M | 12 | 57.9% | -0.22% | +14.45% | View → | |
| 90 | DNLI | $3.20B | 12 | 46.7% | -0.57% | +3.89% | View → | |
| 91 | FDMT | $755.2M | 11 | 38.2% | -2.15% | +6.53% | View → | |
| 92 | LCTX | $235.3M | 11 | 24.2% | -0.80% | +3.40% | View → | |
| 93 | INBX | $1.43B | 11 | 38.7% | -1.12% | +4.73% | View → | |
| 94 | TWST | $12.51B | 10 | 52.0% | -0.01% | +6.32% | View → | |
| 95 | ZURA | $393.9M | 10 | 48.0% | +0.35% | +11.71% | View → | |
| 96 | HLSQ | - | 10 | 26.0% | -1.03% | +4.15% | View → | |
| 97 | EXEL | $14.47B | 10 | 64.0% | +0.06% | +2.17% | View → | |
| 98 | APGE | $10.22B | 10 | 60.0% | +1.28% | +4.60% | View → | |
| 99 | ENGN | $130.0M | 10 | 46.9% | +1.12% | +5.70% | View → | |
| 100 | SRRK | $5.70B | 9 | 31.1% | -0.07% | +6.64% | View → |
🚀 Scan for Alpha in Biological Products, (No Diagnostic Substances)
Don't trade the whole basket.
Use FILTRIX to isolate the top performing stocks among the 144 companies in this sector. Filter by MFE, Volume, and Win Rate instantly.
📊 Biological Products, (No Diagnostic Substances) Sector Intelligence
⚡ High Volatility Sector
The Biological Products, (No Diagnostic Substances) sector (SIC 2836) aggregates data from 144 stocks. With an average Maximum Favorable Excursion (MFE) of +6.52%, this sector is highly aggressive, suited for experienced volatility traders looking for explosive moves.
📈 Statistical Expectancy
Across 5,947 analyzed alerts, the sector shows a
44.5% Win Rate with an average gain of
-0.38%.
⚠️ This suggests a difficult trading environment where strict stock selection is critical.
Focus on the top performers within this sector.
🏆 Sector Leader
The strongest statistical performer in this group is currently
EXEL
, boasting a 64.0% win rate across
10 alerts.
This significantly outperforms the sector average (44.5%), making it a primary watchlist candidate
for traders seeking edge in this space.